Share this
Legal 500 US 2020 Highlights Cooley
June 24, 2020
Chambers USA 2020 Recognizes Cooley Lawyers + Practices
May 13, 2020
Portola Agrees to Sell to Alexion for $1.41 Billion
May 5, 2020
Goldfinch Partners With Gilead to Develop Novel Therapies for Kidney Disease
June 4, 2019
Gossamer Bio – $317 Million IPO
February 21, 2019
SoftBank Vision Fund Leads $400 Million Series C for Relay Therapeutics
December 27, 2018
SoftBank Vision Fund Leads $1.1 Billion Financing of Roivant Sciences
August 14, 2017
Cour and Takeda Partner to Treat Celiac Disease
December 10, 2015
Nexvet Biopharma Closes Initial Public Offering
February 13, 2015
Ascendis Pharma Closes $124 Million Initial Public Offering
CardioKinetix Completes $50 Million Financing
December 19, 2014
Cooley Advises MyoKardia on Collaboration with Sanofi
September 23, 2014
Cooley Advises Adamas Pharmaceuticals on Initial Public Offering
April 30, 2014
Cooley Advises Portola Pharmaceuticals on its $140 Million IPO
May 29, 2013
Dealmakers: Cooley, Davis Polk Guide Portola Pharmaceuticals' Planned IPO (Daily Journal)
May 10, 2013
Cooley Advises Otsuka on its $825 Million Collaboration Agreement to Develop Alzheimer's Drug
March 29, 2013